For the Quarter Ending March 2026
Domperidone Prices in North America
- In United States, the Domperidone Price Index rose quarter-over-quarter in Q1 2026, driven by severe supply constraints.
- The Domperidone Production Cost Trend increased in March 2026 as CPI rose 3.3% and PPI climbed 4.0%.
- Industrial production grew 0.7% in March 2026, while plunging global naphtha supplies constrained upstream petrochemical precursor availability.
- The Manufacturing Index expanded in March 2026, supporting a stable Domperidone Demand Outlook for authorized investigational treatments.
- Retail sales increased 4.0% and unemployment remained stable at 4.3% in March 2026, maintaining consistent healthcare utilization.
- Consumer confidence reached 91.8 in March 2026, even as healthcare expanded access availability remained constrained throughout Q1 2026.
- Domestic inventories remained depleted in Q1 2026, and legal importation remained strictly limited to authorized investigational applications.
- The Domperidone Price Forecast reflected upward pressure in Q1 2026, as the Domperidone Price Index tracked higher.
Why did the price of Domperidone change in March 2026 in North America?
- Severe domestic supply constraints and depleted investigational stockpiles drove market prices upward throughout Q1 2026.
- Rising synthesis costs pushed prices higher in March 2026, reflected by a 4.0% PPI increase.
- Plunging global naphtha supplies in March 2026 restricted upstream petrochemical precursors, elevating overall production expenses.
Domperidone Prices in APAC
- In China, the Domperidone Price Index rose quarter-over-quarter in Q1 2026, driven by rising costs.
- The Producer Price Index grew 0.5% in March 2026, increasing the Domperidone Production Cost Trend.
- A Consumer Price Index increase of 1.0% in March 2026 supported a steady Domperidone Demand Outlook.
- The Manufacturing Index expanded in March 2026, reflecting healthy pharmaceutical demand and active supply replenishment.
- Industrial production grew 5.7% in March 2026, ensuring ample chemical intermediate supply for Domperidone synthesis.
- The urban unemployment rate reached 5.4% in March 2026, driving consumer substitution toward generic formulations.
- Benzene feedstock costs fluctuated upwards in January 2026, directly elevating the overall Domperidone Price Forecast.
- Propylene feedstock supply tightened in Q1 2026 as domestic dehydrogenation unit operating rates plummeted significantly.
Why did the price of Domperidone change in March 2026 in APAC?
- Propylene precursor costs strengthened in March 2026 due to tightening global supply and regional disruptions.
- Petrochemical and derivative inventories depleted in Q1 2026 as regional markets engaged in active destocking.
- The Producer Price Index grew by 0.5% in March 2026, increasing upstream chemical manufacturing costs.
Domperidone Prices in Europe
- In Germany, the Domperidone Price Index rose quarter-over-quarter in Q1 2026, driven by severe supply shortages.
- During March 2026, consumer inflation reached 2.7%, while industrial producer prices declined slightly by -0.2%.
- The Manufacturing Index expanded in March 2026, despite stagnant industrial production at 0.0% during February 2026.
- Retail sales grew 0.7% and unemployment remained stable at 4.2% in February 2026, supporting baseline consumption.
- Negative consumer confidence at -24.7 in March 2026 caused cautious spending, though Domperidone Demand Outlook remained steady.
- The Domperidone Production Cost Trend increased as benzene and toluene feedstock costs surged during March 2026.
- Domperidone inventories and availability plummeted in Q1 2026 following the complete market exit of a supplier.
- Asian import flows weakened in Q1 2026, which elevated the Domperidone Price Forecast during that period.
Why did the price of Domperidone change in March 2026 in Europe?
- Domperidone supply weakened severely in Germany during Q1 2026 after a primary manufacturer ceased distribution.
- Benzene and toluene feedstock costs surged in March 2026 amid escalating Middle East geopolitical conflicts.
- Import volumes from Asia plummeted during Q1 2026 because of ongoing Red Sea shipping disruptions.
For the Quarter Ending December 2025
Domperidone Prices in North America
- In United States, the Domperidone Price Index rose in Q4 2025, influenced by rising costs and robust demand.
- Domperidone production costs rose; Producer Price Index increased 3.0% year-over-year in November 2025.
- Consumer Price Index rose 2.7% year-over-year in December 2025, increasing raw material expenses.
- Domperidone demand strengthened in Q4 2025, as the pharmaceutical industry outperformed.
- US industrial production expanded 2.0% year-over-year in December 2025, supporting stable supply chains.
- Natural gas prices softened in October and retreated in December 2025, but electricity rates increased in November.
- Retail sales increased 3.3% year-over-year in November 2025, reflecting a strong economy.
- The unemployment rate was 4.4% in December 2025, indicating a strong labor market.
- Consumer confidence was 89.1 in December 2025, supporting a stable economic environment.
Why did the price of Domperidone change in December 2025 in North America?
- Rising input costs, with PPI up 3.0% in November 2025, pressured Domperidone production.
- Strong pharmaceutical industry demand in Q4 2025, including innovative therapies, supported Domperidone prices.
- Mixed energy costs, with softening natural gas but rising electricity in November 2025, affected expenses.
Domperidone Prices in APAC
- In China, the Domperidone Price Index fell quarter-over-quarter in Q4 2025, driven by weak domestic demand and declining input costs.
- Domperidone production costs decreased in Q4 2025, as producer prices declined by 1.9% year-over-year in December 2025.
- Domestic demand for Domperidone weakened in China during Q4 2025, reflecting a year-end seasonal slowdown.
- Retail sales growth of 0.9% year-over-year in December 2025 indicated subdued consumer spending, impacting Domperidone demand.
- Chemical producers drew down inventories in Q4 2025 by moderating operating rates due to persistent industry-wide overcapacity.
- Energy-related input costs for Domperidone eased in 2025, supported by generally declining crude oil prices throughout the year.
- China's manufacturing sector expanded in December 2025, supporting stable supply chains for Domperidone production.
- Industrial production grew by 5.2% year-over-year in December 2025, indicating a robust sector supporting supply chains.
- Government expenditure on health and family planning strengthened from October to November 2025, offering some demand support.
Why did the price of Domperidone change in December 2025 in APAC?
- Producer prices declined by 1.9% year-over-year in December 2025, reducing Domperidone production costs in APAC.
- Weak domestic demand and a year-end seasonal slowdown in Q4 2025 impacted Domperidone sales in China.
- Persistent industry-wide overcapacity for general organic chemical inputs pressured Domperidone prices downwards in Q4 2025.
Domperidone Prices in Europe
- In Germany, the Domperidone Price Index fell in Q4 2025, influenced by competitive pressure from abroad in October 2025.
- Domperidone production costs faced downward pressure in December 2025, as producer prices declined 2.5% year-over-year.
- Domperidone demand faced headwinds in December 2025 from low consumer confidence (-17.5) and 6.2% unemployment.
- Domperidone Price Index is forecast to remain pressured in early 2026, reflecting contracting manufacturing activity in December 2025.
- Business sentiment in the German chemical industry deteriorated sharply in October 2025, impacting overall market conditions.
- Energy costs for Domperidone production remained a concern, with natural gas prices volatile in Q4 2025.
- Low capacity utilization (71%) and plummeting order backlogs in October 2025 indicated weak inventory.
- Industrial production rose 0.8% year-over-year in October 2025, stabilizing the broader supply chain.
- Stable consumer purchasing power (CPI 1.8% in December 2025) supported retail sales growth.
Why did the price of Domperidone change in December 2025 in Europe?
- Producer prices declined by 2.5% year-over-year in December 2025, reducing Domperidone production costs.
- Low consumer confidence at -17.5 in December 2025 dampened demand and market sentiment.
- Increased competitive pressure from abroad in October 2025 exerted downward pressure on prices.
For the Quarter Ending September 2025
Domperidone Prices in North America
- In United States, the Domperidone Price Index fell quarter-over-quarter in Q3 2025, driven by deteriorating customer market demand.
- Domperidone production costs increased due to a 2.6 percent rise in the Producer Price Index in August 2025.
- Overall industrial production in the United States inched up by only 0.1 percent year-over-year in September 2025.
- The Consumer Price Index increased 3.0 percent year-over-year in September 2025, impacting overall production expenses.
- Demand for chemicals deteriorated in Q3 2025, with new orders declining in both domestic and foreign markets.
- US natural gas prices saw an uptick in Q3 2025, though easing in September, affecting energy feedstock costs.
- Chemical industry inventories experienced accelerated destocking during Q3 2025, indicating efforts to reduce stock levels.
- U.S. chemical imports from China experienced a steep decline in July 2025, impacting regional supply dynamics.
- The unemployment rate was 4.3 percent in September 2025, supporting consumer spending and healthcare affordability.
Why did the price of Domperidone change in September 2025 in North America?
- Weak customer market demand for chemicals persisted, leading to declining new orders in Q3 2025.
- Producer Price Index rose 2.6 percent in August 2025, increasing input costs for Domperidone manufacturing.
- Chemical production levels declined in Q3 2025, tightening regional supply due to maintenance turnarounds.
Domperidone Prices in Europe
- In Germany, the Domperidone Price Index remained stable in Q3 2025, influenced by contracting manufacturing activity.
- Domperidone production costs remained elevated in Q3 2025, despite a -1.7% PPI decline in September 2025.
- European natural gas prices softened in July and August 2025, then trended upward in September 2025.
- German electricity prices strengthened in July 2025 and fluctuated in September 2025, raising input costs.
- Demand for generic Domperidone in Germany saw broad market access during Q3 2025 due to lower costs.
- Overall German industrial production declined by -1.0% year-over-year in September 2025, dampening demand.
- Consumer confidence in Germany declined to -23.6 in September 2025, impacting discretionary spending.
- A 2.4% CPI in September 2025 indicated moderate inflation, increasing operational costs for Domperidone producers.
- German chemical and pharmaceutical production declined in Q3 2025, with capacity utilization below profitability.
Why did the price of Domperidone change in September 2025 in Europe?
- Contracting manufacturing activity in September 2025, indicated by the Manufacturing Index, dampened demand.
- High input costs persisted in Q3 2025, despite a -1.7% PPI decline in September 2025.
- Weak consumer confidence, at -23.6 in September 2025, reduced demand for OTC Domperidone.
Domperidone Prices in APAC
- In China, the Domperidone Price Index fell quarter-over-quarter in Q3 2025, driven by deflationary pressures.
- Domperidone production costs declined in Q3 2025, influenced by depressed ethylene feedstock and a slight dip in benzene in August.
- Pharmaceutical raw material demand strengthened in 2025, despite China's Manufacturing Index contracting in September 2025.
- Industrial production increased by 6.5% year-on-year in September 2025, supporting a favorable economic environment.
- Retail sales grew by 3.0% year-on-year in September 2025, bolstering consumer demand for over-the-counter products.
- New U.S. tariffs on pharmaceutical imports from China in July 2025 increased costs, impacting Domperidone trade flows.
- Ample ethylene inventories and rising global oil inventories in Q3 2025 contributed to downward pressure on feedstock.
- China's chemical overcapacity in Q3 2025, alongside self-sufficiency goals, exerted pressure on Domperidone markets.
Why did the price of Domperidone change in September 2025 in APAC?
- Deflationary pressures, with CPI at -0.3% year-on-year in September 2025, reduced overall pricing power.
- Production costs declined due to a -2.3% year-on-year PPI in September 2025 and depressed ethylene feedstock.
- Weak overall chemical demand in Q3 2025, despite positive retail sales, limited Domperidone price increases.
For the Quarter Ending December 2022
North America
This product is discontinued in this region.
APAC
Domperidone API witnessed a mixed pricing sentiments trend throughout the fourth quarter of 2022 in the Asia Pacific region. The prices declined consistently during October, followed by the trend of September owing to reduced demand which compelled the local merchants to decrease their domestic prices. Following November, the demand surged gradually, which was balanced by overall inventories resulting from the distributors within the domestic market. Later in December, a surge in COVID-19 cases affected the supplies and end-user demand, which led to piled-up stocks of Domperidone. Overall, the price of Domperidone noted at the end of the fourth quarter was assembled at USD 107700/MT FOB Shanghai in China.
Europe
This product is discontinued in this region.
